查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1946611

2026年全球分子诊断（基于次世代定序（NGS））市场报告

Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，基于次世代定序（NGS）的分子诊断市场呈现显着成长，预计将从2025年的22.6亿美元成长到2026年的24.3亿美元，复合年增长率（CAGR）为7.6%。过去几年的成长可归因于多种因素，例如遗传疾病检测的增加、高通量定序技术的进步、人们对分子诊断认识的提高、分子诊断技术在临床检查室的广泛应用以及定序试剂的技术进步。

基于次世代定序（NGS）的分子诊断市场预计将在未来几年强劲成长，到2030年达到32.3亿美元，复合年增长率（CAGR）为7.3%。预测期内的成长要素包括人工智慧和机器学习在诊断领域的应用、云端基因组学平台的扩展、携带式和照护现场定序的开发、个人化医疗的日益普及以及诊断公司与生物技术公司之间的合作。预测期内的关键趋势包括人工智慧辅助分子诊断、云端基因组学平台、携带式定序设备、生物资讯流程整合以及疾病标记的快速检测。

预计未来几年，感染疾病率的上升将推动基于次世代定序（NGS）技术的分子诊断市场发展。感染疾病是由细菌、病毒、真菌和寄生虫等微生物引起的，这些微生物侵入人体并在体内繁殖，破坏正常生理功能。全球旅行和人口流动的增加促进了病原体在不同地区和国界之间的传播，导致感染疾病病例增加。基于NGS的分子诊断技术透过对病原体进行全面、精准的分析，能够同时识别多种微生物，从而帮助检测这些疾病。这缩短了诊断时间，提高了治疗的准确性和患者照护。例如，根据英国卫生安全局2024年2月发布的报告，英格兰的结核病病例数增加了10.7%，从2022年的4,380例增加到2023年的4,850例。感染疾病率的上升正在推动对基于次世代定序（NGS）技术的分子诊断技术的需求。

在基于次世代定序(NGS) 的分子诊断市场中，主要企业正致力于开发先进的 NGS 检测panel，以提高基因检测的准确性、可近性和效率。 NGS panel 是一组标靶基因或基因组区域，利用 NGS 技术同时进行分析，以识别具有临床意义的突变，从而实现更快、更准确的分子诊断。例如，2024 年 4 月，美国诊断公司 Pillar Biosciences 的 oncoReveal CDx 泛癌实体瘤体外诊断试剂盒获得 FDA核准，该试剂盒可在单次多重反应中检测 22 个具有临床意义的基因。该 panel 专为 Illumina MiSeq 检体系统设计，从检体到报告大约需要 48 小时，单次运行最多可处理 46 个临床检体。 Oncorevir CDx 包括 KRAS（用于结直肠癌的 EGFR标靶治疗）和 EGFR（用于非小细胞肺癌的 TKI 治疗）的伴随诊断索赔，透过更全面、更有效地检测可操作的基因组改变，有助于改善临床决策。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球次世代定序（NGS）分子诊断市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 人工智慧辅助分子诊断
    • 云基因组分析平台
    • 携带式定序仪
    • 生物资讯流程整合
    • 快速检测疾病标记

第五章 终端用户产业市场分析

  • 研究中心和学术机构
  • 医院和临床检查室
  • 生物製药公司
  • 基因检测实验室
  • 合约研究组织（CRO）

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球次世代定序（NGS）分子诊断市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球次世代定序（NGS）分子诊断市场规模、比较及成长率分析
  • 全球次世代定序（NGS）分子诊断市场表现：规模与成长，2020-2025年
  • 全球次世代定序(NGS) 分子诊断市场预测：规模与成长，2025-2030 年，2035 年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按类型
  • 仪器、试剂及耗材、软体及服务、检测板及分析、样品製备试剂盒
  • 透过使用
  • 微生物学、感染疾病、肿瘤学、基因检测及其他应用领域
  • 最终用户
  • 研究机构、学术机构、医院、临床检查室和其他最终用户
  • 按类型细分：设备
  • 桌上型定序仪、高通量定序仪、可携式或手持式定序仪、临床或诊断定序仪、自动化样品製备系统、数据分析和生物资讯硬体
  • 按类型细分：试剂和耗材
  • 定序试剂和试剂盒、样品製备试剂、标靶富集试剂、扩增试剂、定序流动池和晶片、去氧核糖核酸(DNA) 或核糖核酸 (RNA) 萃取试剂、品管试剂
  • 按类型细分：软体和服务
  • 数据分析软体、生物资讯学流程、基于云端的基因组平台、临床解读工具、数据储存和管理服务、客製化生物资讯服务、基因组资料库服务
  • 按类型细分：检测板和检测方法
  • 肿瘤检测组合、感染疾病组合、带因者筛检组合、生殖健康检测组合、罕见疾病或遗传疾病检测组合、药物基因体学检测组合、全EXOME组或全基因组检测
  • 按类型细分：样本製备试剂盒
  • 去氧核糖核酸(DNA) 萃取试剂盒、核糖核酸 (RNA) 萃取试剂盒、样品製备盒、标靶富集试剂盒、扩增纯化试剂盒、单细胞製备试剂盒、低丰度或劣化试剂盒

第十章 区域与国家分析

  • 全球次世代定序(NGS) 分子诊断市场：按地区划分，实际结果与预测，2020-2025 年、2025-2030 年预测、2035 年预测
  • 全球次世代定序(NGS) 分子诊断市场：国家/地区、绩效与预测，2020-2025 年、2025-2030 年预测、2035 年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 次世代定序（NGS）分子诊断市场：竞争格局与市场份额，2024年
  • 次世代定序（NGS）分子诊断市场：公司估值矩阵
  • 次世代定序（NGS）分子诊断市场：公司概况
    • Thermo Fisher Scientific
    • Siemens Healthineers AG
    • Agilent Technologies Inc.
    • Illumina Inc.
    • PerkinElmer Inc.

第37章：其他领先和创新企业

  • Bio-Rad Laboratories Inc., Qiagen NV, Amoy Diagnostics Co. Ltd., Tempus Labs Inc., Myriad Genetics Inc., Epigenomics AG, Precision for Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., Caris Life Sciences Inc., Foundation Medicine Inc., Oxford Nanopore Technologies Ltd., Freenome Inc., Burning Rock Biotech

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年次世代定序（NGS）分子诊断市场：提供新机会的国家
  • 2030年次世代定序（NGS）分子诊断市场：充满新机会的细分市场
  • 2030年次世代定序（NGS）分子诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME5MNGSN04_G26Q1

Next-generation sequencing (NGS)-based molecular diagnostics is a technology-driven approach that uses high-throughput sequencing to analyze genetic material with precision and speed. It enables detection of genetic variations, mutations, and disease markers at the molecular level, providing detailed insights into the genetic basis of health and disease. This approach supports precise, data-driven diagnostics by combining sequencing technologies with advanced bioinformatics.

The primary types of NGS-based molecular diagnostics include instruments, reagents and consumables, software and services, panels and assays, and sample preparation kits. NGS instruments are the hardware platforms, such as sequencers and automation workstations, used to perform high-throughput DNA/RNA sequencing. Applications include microbiology, infectious diseases, oncology, genetic testing, and other areas. End users include research centers, academic institutions, hospitals, clinical laboratories, and other organizations.

Tariffs have influenced the NGS-based molecular diagnostics market by raising the cost of imported instruments, sequencing kits, and bioinformatics software. Hospitals, research labs, and diagnostic centers are most affected, particularly in Asia-Pacific and Europe. Segments like high-throughput sequencers and library preparation kits face increased costs. Positive outcomes include promotion of local manufacturing and domestic software development, which enhances supply chain resilience and innovation.

The next-generation sequencing (ngs)-based molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides next-generation sequencing (ngs)-based molecular diagnostics market statistics, including next-generation sequencing (ngs)-based molecular diagnostics industry global market size, regional shares, competitors with a next-generation sequencing (ngs)-based molecular diagnostics market share, detailed next-generation sequencing (ngs)-based molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the next-generation sequencing (ngs)-based molecular diagnostics industry. This next-generation sequencing (ngs)-based molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The next-generation sequencing (ngs)-based molecular diagnostics market size has grown strongly in recent years. It will grow from $2.26 billion in 2025 to $2.43 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to growth in genetic disorder testing, development of high-throughput sequencing, rising awareness of molecular diagnostics, adoption in clinical labs, technological improvements in sequencing reagents.

The next-generation sequencing (ngs)-based molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.23 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to integration of ai and machine learning in diagnostics, expansion of cloud-based genomic platforms, development of portable and point-of-care sequencing devices, rise in personalized medicine applications, collaborations between diagnostics and biotech firms. Major trends in the forecast period include AI-assisted molecular diagnostics, cloud genomic analysis platforms, portable sequencing devices, integration of bioinformatics pipelines, rapid disease marker detection.

The rising incidence of infectious diseases is expected to drive growth in the next-generation sequencing (NGS)-based molecular diagnostics market in the coming years. Infectious diseases are illnesses caused by microorganisms such as bacteria, viruses, fungi, or parasites that invade and multiply within the body, disrupting normal functions. Increasing global travel and migration contribute to the spread of pathogens across regions and borders, fueling the rise in infectious disease cases. NGS-based molecular diagnostics aids in detecting these diseases by offering comprehensive and precise analysis of pathogens, enabling simultaneous identification of multiple microorganisms, which shortens diagnostic time and improves treatment accuracy and patient care. For example, in February 2024, the UK Health Security Agency reported that tuberculosis cases in England increased by 10.7%, rising from 4,380 in 2022 to 4,850 in 2023. Consequently, the growing incidence of infectious diseases is propelling the demand for NGS-based molecular diagnostics.

Major companies operating in the next-generation sequencing (NGS)-based molecular diagnostics market are concentrating on developing advanced NGS-based panels to improve the accuracy, accessibility, and efficiency of genetic testing. NGS panels are targeted collections of genes or genomic regions analyzed simultaneously using NGS technology to identify clinically relevant mutations, enabling faster and more precise molecular diagnostics. For example, in April 2024, Pillar Biosciences, a US-based diagnostics company, received FDA approval for its oncoReveal CDx pan-cancer solid tumor IVD kit, which examines 22 clinically relevant genes in a single multiplex reaction. Designed for use with Illumina's MiSeq Dx system, the panel offers a sample-to-report time of around 48 hours and can process up to 46 clinical samples per run. OncoReveal CDx includes companion diagnostic claims for KRAS (for EGFR-targeted therapy in colorectal cancer) and EGFR (for TKI therapy in non-small-cell lung cancer), allowing more comprehensive and efficient detection of actionable genomic alterations to enhance clinical decision-making.

In January 2023, QIAGEN NV, a molecular diagnostics and life sciences company based in Germany, acquired Verogen Inc. for an undisclosed sum. This acquisition aims to enhance QIAGEN's leadership in human identification and forensic genomics by integrating Verogen's specialized NGS technologies into its broader molecular diagnostics portfolio. This expansion strengthens QIAGEN's presence in public sector forensics and private sector applications such as genetic genealogy. Verogen Inc. is a US-based company specializing in NGS solutions for forensic genomics.

Major companies operating in the next-generation sequencing (ngs)-based molecular diagnostics market are Thermo Fisher Scientific, Siemens Healthineers AG, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Amoy Diagnostics Co. Ltd., Tempus Labs Inc., Myriad Genetics Inc., Epigenomics AG, Precision for Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., Caris Life Sciences Inc., Foundation Medicine Inc., Oxford Nanopore Technologies Ltd., Freenome Inc., Burning Rock Biotech, Element Biosciences Inc., Asuragen Inc., Bionano Genomics Inc., Genomic Health Inc., TATAA Biocenter AB

North America was the largest region in the next-generation sequencing (NGS)-based molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation sequencing (ngs)-based molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the next-generation sequencing (ngs)-based molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The next-generation sequencing (NGS)-based molecular diagnostics market includes revenues earned by entities by providing services, such as clinical genomic testing, cancer genomic profiling, infectious disease detection, liquid biopsy testing, and pharmacogenomics testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The next-generation sequencing (NGS)-based molecular diagnostics market also includes sales of tumor mutation panels, carrier screening kits, drug response panels, companion diagnostic kits, and whole-genome metagenomics kits. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses next-generation sequencing (ngs)-based molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for next-generation sequencing (ngs)-based molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The next-generation sequencing (ngs)-based molecular diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Instruments; Reagents And Consumables; Software And Services; Panels And Assays; Sample Preparation Kits
  • 2) By Application: Microbiology; Infectious Diseases; Oncology; Genetic Tests; Other Applications
  • 3) By End User: Research Centers And Academics; Hospitals And Clinical Laboratories; Other End Users
  • Subsegments:
  • 1) By Instruments: Benchtop Sequencers; High-Throughput Sequencers; Portable Or Handheld Sequencers; Clinical Or Diagnostic Sequencers; Automated Library Preparation Systems; Data Analysis And Bioinformatics Hardware
  • 2) By Reagents And Consumables: Sequencing Reagents And Kits; Library Preparation Reagents; Target Enrichment Reagents; Amplification Reagents; Sequencing Flow Cells And Chips; Deoxyribonucleic Acid (DNA) Or Ribonucleic Acid (RNA) Extraction Reagents; Quality Control Reagents
  • 3) By Software And Services: Data Analysis Software; Bioinformatics Pipelines; Cloud-Based Genomic Platforms; Clinical Interpretation Tools; Data Storage And Management Services; Custom Bioinformatics Services; Genomic Database Services
  • 4) By Panels And Assays: Oncology Panels; Infectious Disease Panels; Carrier Screening Panels; Reproductive Health Panels; Rare Disease Or Genetic Disorder Panels; Pharmacogenomics Panels; Whole-Exome Or Whole-Genome Assays
  • 5) By Sample Preparation Kits: Deoxyribonucleic Acid (DNA) Extraction Kits; Ribonucleic Acid (RNA) Extraction Kits; Library Preparation Kits; Target Enrichment Kits; Amplification And Cleanup Kits; Single-Cell Preparation Kits; Low-Input Or Degraded Sample Kits
  • Companies Mentioned: Thermo Fisher Scientific; Siemens Healthineers AG; Agilent Technologies Inc.; Illumina Inc.; PerkinElmer Inc.; Bio-Rad Laboratories Inc.; Qiagen N.V.; Amoy Diagnostics Co. Ltd.; Tempus Labs Inc.; Myriad Genetics Inc.; Epigenomics AG; Precision for Medicine Inc.; Invitae Corporation; NeoGenomics Laboratories Inc.; Guardant Health Inc.; Caris Life Sciences Inc.; Foundation Medicine Inc.; Oxford Nanopore Technologies Ltd.; Freenome Inc.; Burning Rock Biotech; Element Biosciences Inc.; Asuragen Inc.; Bionano Genomics Inc.; Genomic Health Inc.; TATAA Biocenter AB
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Ai-Assisted Molecular Diagnostics
    • 4.2.2 Cloud Genomic Analysis Platforms
    • 4.2.3 Portable Sequencing Devices
    • 4.2.4 Integration Of Bioinformatics Pipelines
    • 4.2.5 Rapid Disease Marker Detection

5. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Analysis Of End Use Industries

  • 5.1 Research Centers And Academic Institutes
  • 5.2 Hospitals And Clinical Laboratories
  • 5.3 Biopharmaceutical Companies
  • 5.4 Genetic Testing Laboratories
  • 5.5 Contract Research Organizations (Cros)

6. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Segmentation

  • 9.1. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Instruments, Reagents And Consumables, Software And Services, Panels And Assays, Sample Preparation Kits
  • 9.2. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Microbiology, Infectious Diseases, Oncology, Genetic Tests, Other Applications
  • 9.3. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Research Centers And Academics, Hospitals And Clinical Laboratories, Other End Users
  • 9.4. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Benchtop Sequencers, High-Throughput Sequencers, Portable Or Handheld Sequencers, Clinical Or Diagnostic Sequencers, Automated Library Preparation Systems, Data Analysis And Bioinformatics Hardware
  • 9.5. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Sequencing Reagents And Kits, Library Preparation Reagents, Target Enrichment Reagents, Amplification Reagents, Sequencing Flow Cells And Chips, Deoxyribonucleic Acid (DNA) Or Ribonucleic Acid (RNA) Extraction Reagents, Quality Control Reagents
  • 9.6. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Data Analysis Software, Bioinformatics Pipelines, Cloud-Based Genomic Platforms, Clinical Interpretation Tools, Data Storage And Management Services, Custom Bioinformatics Services, Genomic Database Services
  • 9.7. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Panels And Assays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oncology Panels, Infectious Disease Panels, Carrier Screening Panels, Reproductive Health Panels, Rare Disease Or Genetic Disorder Panels, Pharmacogenomics Panels, Whole-Exome Or Whole-Genome Assays
  • 9.8. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Sample Preparation Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Deoxyribonucleic Acid (DNA) Extraction Kits, Ribonucleic Acid (RNA) Extraction Kits, Library Preparation Kits, Target Enrichment Kits, Amplification And Cleanup Kits, Single-Cell Preparation Kits, Low-Input Or Degraded Sample Kits

10. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Regional And Country Analysis

  • 10.1. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

  • 11.1. Asia-Pacific Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

  • 12.1. China Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

  • 13.1. India Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

  • 14.1. Japan Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

  • 15.1. Australia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

  • 16.1. Indonesia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

  • 17.1. South Korea Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

  • 18.1. Taiwan Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

  • 19.1. South East Asia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

  • 20.1. Western Europe Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

  • 21.1. UK Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

  • 22.1. Germany Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

  • 23.1. France Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

  • 24.1. Italy Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

  • 25.1. Spain Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

  • 26.1. Eastern Europe Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

  • 27.1. Russia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

  • 28.1. North America Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

  • 29.1. USA Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

  • 30.1. Canada Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

  • 31.1. South America Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

  • 32.1. Brazil Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

  • 33.1. Middle East Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

  • 34.1. Africa Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Regulatory and Investment Landscape

36. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Competitive Landscape And Company Profiles

  • 36.1. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Company Profiles
    • 36.3.1. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Other Major And Innovative Companies

  • Bio-Rad Laboratories Inc., Qiagen N.V., Amoy Diagnostics Co. Ltd., Tempus Labs Inc., Myriad Genetics Inc., Epigenomics AG, Precision for Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., Caris Life Sciences Inc., Foundation Medicine Inc., Oxford Nanopore Technologies Ltd., Freenome Inc., Burning Rock Biotech

38. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

40. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market High Potential Countries, Segments and Strategies

  • 40.1 Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer